Filing Details
Boundless Bio, Inc. (NASDAQ:BOLD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:BOLD
Boundless Bio, Inc. (BOLD) Files Quarterly Report for Q0
Boundless Bio, Inc. (NASDAQ:BOLD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
Boundless Bio, Inc. (NASDAQ:BOLD) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Boundless Bio, Inc. (NASDAQ: BOLD) filed its quarterly report (Form 10-Q) on August 7, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $2.89 with a market capitalization of $25.7 million as of the filing date.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual report.
Market Context
Boundless Bio, Inc.'s stock currently trades at $2.89 with a market capitalization of $25.7M.
The 10-Q provides Boundless Bio, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Boundless Bio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BOLD Stock Page
Frequently Asked Questions
Where can I read BOLD's SEC filings?
Browse all filings on our BOLD SEC filings page.
What types of SEC filings does Boundless Bio, Inc. file?
Public companies like Boundless Bio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
